Literature DB >> 29344261

T cell acute lymphoblastic lymphoma complicated with myeloid sarcoma in an adult: A case report.

Ying Wang1, Shupeng Wen1, Zhiyun Niu1, Lina Xing1, Fuxu Wang1, Xuejun Zhang1.   

Abstract

The present case report describes a rare case of T cell acute lymphoblastic lymphoma (T-LBL) in the lymph node with myeloid sarcoma in the pericardium. A 33-year-old Chinese male was admitted to hospital on 4 July 2015 exhibiting a fever and having experienced wheezing and fatigue for the previous 7 days. Routine pathological, computed tomographic, cytological and immunophenotypic observations revealed a diagnosis of T-LBL in the lymph node on 7 August 2015, without evidence of bone marrow (BM) involvement. The patient received induction chemotherapy for T-LBL and achieved partial remission. The patient was identified to have multiple serous effusion and analysis of pericardial effusion cells revealed the diagnosis of T-LBL with extramedullary myeloid sarcoma (without BM involvement) on 25 November 2015. On 30 December 2015, the patient was identified to exhibit proliferation of primary myeloid cells in the peripheral blood and BM, and an abnormal karyotype in BM cells, indicating that the complicated myeloid sarcoma involved the BM. No matched donor was available so the patient received chemotherapy to manage the disease. The patient was discharged on 31 January 2016 and ceased treatment. The patient succumbed on 19 February 2016 at home. To the best of our knowledge, T-LBL complicated with myeloid sarcoma had not been previously reported in Chinese adult male patients. In addition, the involvement of the BM and aberrant karyotype of the complicated myeloid sarcoma in the patient were rare.

Entities:  

Keywords:  T cell acute lymphoblastic lymphoma; bone marrow; myeloid sarcoma; serous effusion

Year:  2017        PMID: 29344261      PMCID: PMC5755172          DOI: 10.3892/ol.2017.7187

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy.

Authors:  K Tokita; K Maki; J Tadokoro; Y Nakamura; Y Arai; K Sasaki; M Eguchi-Ishimae; M Eguchi; K Mitani
Journal:  Leukemia       Date:  2006-11-23       Impact factor: 11.528

2.  T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy.

Authors:  L V Abruzzo; E S Jaffe; J D Cotelingam; J Whang-Peng; V Del Duca; L J Medeiros
Journal:  Am J Surg Pathol       Date:  1992-03       Impact factor: 6.394

3.  Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation-an uncommon presentation in adults.

Authors:  S Krishnan; K Sabai; C Chuah; S Y Tan
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

4.  Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Authors:  Sonali M Smith; Michelle M Le Beau; Dezheng Huo; Theodore Karrison; Ronald M Sobecks; John Anastasi; James W Vardiman; Janet D Rowley; Richard A Larson
Journal:  Blood       Date:  2003-03-06       Impact factor: 22.113

5.  Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.

Authors:  G Metzgeroth; C Walz; J Score; R Siebert; S Schnittger; C Haferlach; H Popp; T Haferlach; P Erben; J Mix; M C Müller; H Beneke; L Müller; F Del Valle; W E Aulitzky; G Wittkowsky; N Schmitz; C Schulte; K Müller-Hermelink; E Hodges; S J Whittaker; F Diecker; H Döhner; P Schuld; R Hehlmann; A Hochhaus; N C P Cross; A Reiter
Journal:  Leukemia       Date:  2007-03-22       Impact factor: 11.528

6.  A simple R banding technic.

Authors:  R S Verma; H A Lubs
Journal:  Am J Hum Genet       Date:  1975-01       Impact factor: 11.025

Review 7.  Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.

Authors:  J Pedersen-Bjergaard; D H Christiansen; F Desta; M K Andersen
Journal:  Leukemia       Date:  2006-09-21       Impact factor: 11.528

8.  Chronic myelogenous leukemia presenting in blast phase with nodal, bilineal myeloid sarcoma and T-lymphoblastic lymphoma in a child.

Authors:  Xueyan Chen; Joe C Rutledge; David Wu; Min Fang; Kent E Opheim; Min Xu
Journal:  Pediatr Dev Pathol       Date:  2012-11-21

Review 9.  Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome.

Authors:  Barbara J Bain; Sarah H Fletcher
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

10.  TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.

Authors:  Rafael Bejar; Allegra Lord; Kristen Stevenson; Michal Bar-Natan; Albert Pérez-Ladaga; Jacques Zaneveld; Hui Wang; Bennett Caughey; Petar Stojanov; Gad Getz; Guillermo Garcia-Manero; Hagop Kantarjian; Rui Chen; Richard M Stone; Donna Neuberg; David P Steensma; Benjamin L Ebert
Journal:  Blood       Date:  2014-09-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.